Summit Therapeutics Other Non-Current Liabilities 2015-2024 | SMMT
Summit Therapeutics other non-current liabilities for the quarter ending September 30, 2024 were $0.002B, a 16.26% increase year-over-year.
- Summit Therapeutics other non-current liabilities for 2023 were $0.002B, a 9.31% increase from 2022.
- Summit Therapeutics other non-current liabilities for 2022 were $0.001B, a 48.52% decline from 2021.
- Summit Therapeutics other non-current liabilities for 2021 were $0.003B, a 10.55% increase from 2020.